elaVida® (Olive Hydroxytyrosol — DSM)

Olea europaea
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

elaVida® is an olive (Olea europaea) polyphenol ingredient from DSM, standardized for hydroxytyrosol, a well-researched antioxidant in extra virgin olive oil. It is positioned for heart health by protecting blood lipids from oxidative damage, the basis of an approved olive-polyphenol health claim.

Studied Dose About 5 mg of hydroxytyrosol per day (the level in 20 g of extra virgin olive oil).
Active Compound Olive polyphenol extract standardized for hydroxytyrosol.

Benefits

Protects LDL cholesterol

Olive polyphenols at about 5 mg of hydroxytyrosol per day help protect LDL (bad) cholesterol from oxidative damage, the basis of the approved EFSA olive-polyphenol health claim.

Cardiovascular support

By protecting blood lipids and supporting blood-vessel health, olive polyphenols support cardiovascular wellness.

Antioxidant defense

Hydroxytyrosol is a well-studied olive polyphenol antioxidant that helps protect cells from oxidative stress.

Mechanism of action

1

Lipid protection

Hydroxytyrosol embeds with LDL particles and shields their fats from oxidation, a key step in keeping arteries healthy.

2

Free-radical scavenging

Hydroxytyrosol's structure makes it an effective scavenger of free radicals in laboratory studies.

Clinical trials

1
Olive Leaf Extract (Oleuropein) and Cardiovascular Markers — RCT
PubMed

Randomized placebo-controlled trial of olive LEAF extract — standardized to oleuropein, a different polyphenol than the hydroxytyrosol in elaVida — on cardiovascular health markers. (Stevens et al. 2021, European Journal of Nutrition)

Adults.

This trial tested olive leaf extract (oleuropein), a different polyphenol than the hydroxytyrosol in elaVida. The regulatory basis for elaVida's LDL claim is the approved EFSA olive-polyphenol health claim (5 mg hydroxytyrosol per day helps protect blood lipids from oxidative stress), not this study.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Blood pressure medication — olive polyphenols may have a mild additive effect; monitor.
Generally compatible with a healthy diet.
Tell your doctor if you take cardiovascular medication.

Frequently asked questions about elaVida® (Olive Hydroxytyrosol — DSM)

What is elaVida?

elaVida® is an olive (Olea europaea) polyphenol ingredient from DSM, standardized for hydroxytyrosol, a well-researched antioxidant in extra virgin olive oil. It is positioned for heart health by protecting blood lipids from oxidative damage, the basis of an approved olive-polyphenol health claim.

What is elaVida used for?

elaVida is researched primarily for Cardiovascular and Antioxidant. Olive polyphenols at about 5 mg of hydroxytyrosol per day help protect LDL (bad) cholesterol from oxidative damage, the basis of the approved EFSA olive-polyphenol health claim.

What is the recommended dosage of elaVida?

The clinically studied dose is About 5 mg of hydroxytyrosol per day (the level in 20 g of extra virgin olive oil). Always follow the product label and check with a healthcare provider for personal advice.

Is elaVida safe, and does it have side effects?

For most healthy adults, elaVida is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild digestive upset is occasionally reported. It may also interact with some medications. elaVida is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does elaVida interact with any medications?

Possible interactions include: Blood pressure medication — olive polyphenols may have a mild additive effect; monitor. Generally compatible with a healthy diet. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for elaVida?

NutraSmarts rates the evidence for elaVida as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Stevens Y, Winkens B, Jonkers D, et al. The effect of olive leaf extract on cardiovascular health markers: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021;60(4):2111-2120..PubMedUsed to support: RCT on olive LEAF extract (oleuropein) — a different polyphenol than hydroxytyrosol; included for context, not as direct evidence for elaVida. elaVida's LDL-protection claim rests on the EFSA olive-polyphenol health claim.